|
Abstract Objective To explore the effect of entecavir on immunologic functions of patients with chronic hepatitis B.Methods Totally 231 patients with chronic hepatitis B were selected and randomly divided into observation group (116 cases) and control group (115 cases). Routine liver-protecting treatment was given to control group, and observation group was added with entecavir. The level of HBV-DNA, liver function indexes and change of immunologic functions were observed.Results After treatment, the level of HBV-DNA was lower and the improvement of liver function indexes were better in observation group than those in control group, and there was statistically significant difference (P＜0.05). The level of CD4+T cells and their ratio to CD8+T cells were significantly increased, the percentage of CD5+CD19+ B cells was obviously decreased, and the level of C3, C4 was significantly increased in observation group after treatment. Conclusion with control group, the difference was of statistical significance (P＜0.05). There were no serious adverse reactions in either group.Conclusion Entecavir, which is safe for chronic hepatitis B, can reduce the expression of HBV DNA , improve the liver functions and immunological functions.
|
|
Published: 02 November 2016
|
|
|
|
2016, Vol. 34 
